DRUG PREDICTION PLATFORM Trademark
Trademark Overview
On Friday, March 10, 2023, a trademark application was filed for DRUG PREDICTION PLATFORM with the United States Patent and Trademark Office. The USPTO has given the DRUG PREDICTION PLATFORM trademark a serial number of 97834146. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, April 18, 2024. This trademark is owned by First Ascent Biomedical Inc.. The DRUG PREDICTION PLATFORM trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:
Medical services in the field of cancer treatment; cancer treatment consulting services for cancer patients; cancer treatment services; precision therapy services; DNA sequencing services; phenotype screening services; personalized pharmacogenomics services; biomarker validation services; biotechnology services; targeted and personalized healthcare services; cancer drug treatment selection consulting services
Cancer research services; cancer drug treatment development services; cancer treatment drug development consulting services; cancer drug treatment testing services for others; Medical research services in the field of cancer
General Information
| Serial Number | 97834146 |
| Word Mark | DRUG PREDICTION PLATFORM |
| Filing Date | Friday, March 10, 2023 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Thursday, April 18, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Medical services in the field of cancer treatment; cancer treatment consulting services for cancer patients; cancer treatment services; precision therapy services; DNA sequencing services; phenotype screening services; personalized pharmacogenomics services; biomarker validation services; biotechnology services; targeted and personalized healthcare services; cancer drug treatment selection consulting services |
| Goods and Services | Cancer research services; cancer drug treatment development services; cancer treatment drug development consulting services; cancer drug treatment testing services for others; Medical research services in the field of cancer |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 31, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | Thursday, January 1, 1970 |
| First Use In Commerce Date | Thursday, January 1, 1970 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 31, 2023 |
| Primary Code | 044 |
| First Use Anywhere Date | Thursday, January 1, 1970 |
| First Use In Commerce Date | Thursday, January 1, 1970 |
Trademark Owner History
| Party Name | First Ascent Biomedical Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Miami, US 331742526 |
Trademark Events
| Event Date | Event Description |
| Tuesday, March 14, 2023 | NEW APPLICATION ENTERED |
| Friday, March 31, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, December 7, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, December 27, 2023 | NON-FINAL ACTION E-MAILED |
| Wednesday, December 27, 2023 | NON-FINAL ACTION WRITTEN |
| Wednesday, December 27, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, April 18, 2024 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Thursday, April 18, 2024 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
